These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7775136)

  • 1. Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.
    Ravdin PM; Green S; Doroshow JH; Martino S
    Invest New Drugs; 1994; 12(4):333-6. PubMed ID: 7775136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Jenkins TR; Tangen C; Macdonald JS; Weiss G; Chapman R; Hantel A
    Invest New Drugs; 1993 Nov; 11(4):329-31. PubMed ID: 8157474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.
    Hantel A; Tangen C; Gluck WL; Macdonald JS
    Invest New Drugs; 1994; 12(2):159-61. PubMed ID: 7860236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy.
    Ingle JN; Kuross SA; Mailliard JA; Loprinzi CL; Jung SH; Nelimark RA; Krook JE; Long HJ
    Cancer; 1994 Sep; 74(6):1733-8. PubMed ID: 8082075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study.
    Sosman JA; Flaherty LE; Liu PY; Fletcher W; Thompson JA; Hantel A; Sondak V
    Invest New Drugs; 1995; 13(1):83-7. PubMed ID: 7499114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
    Pazdur R; Bready B; Scalzo AJ; Brandof JE; Close DR; Kolbye S; Winn RJ
    Invest New Drugs; 1994; 12(3):263-5. PubMed ID: 7896547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.
    Zalupski MM; Benedetti J; Balcerzak SP; Hutchins LF; Belt RJ; Hantel A; Goodwin JW
    Invest New Drugs; 1993 Nov; 11(4):337-41. PubMed ID: 8157477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.
    Malviya VK; Liu PY; Goldberg DA; Hantel A; O'Toole RV; Roach RW; Conrad ME; Alberts DS
    Anticancer Drugs; 1996 Jul; 7(5):527-30. PubMed ID: 8862719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.
    Albain KS; Liu PY; Hantel A; Poplin EA; O'Toole RV; Wade JL; Maddox AM; Alberts DS
    Gynecol Oncol; 1995 Jun; 57(3):407-11. PubMed ID: 7774846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.
    Taylor SA; Benedetti J; Schuller D; Richman SP; Broun GO; Hantel A
    Invest New Drugs; 1993; 11(2-3):227-9. PubMed ID: 8262737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
    Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
    J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.
    Allen A; Wolf M; Crawford ED; Davis MP; Natale RB; Barnett ML
    Invest New Drugs; 1992 Jul; 10(2):129-32. PubMed ID: 1500267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.
    Savarese DM; Denicoff AM; Berg SL; Hillig M; Baker SP; O'Shaughnessy JA; Chow C; Otterson GA; Balis FM; Poplack DG
    J Clin Oncol; 1993 Sep; 11(9):1795-803. PubMed ID: 7689093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Von Hoff DD; Neidhart JA; Tranum BL; Fabian C; Jones SE
    Invest New Drugs; 1983; 1(2):181-4. PubMed ID: 6678866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
    Hantel A; Donehower RC; Rowinsky EK; Vance E; Clarke BV; McGuire WP; Ettinger DS; Noe DA; Grochow LB
    Cancer Res; 1990 Jun; 50(11):3284-8. PubMed ID: 2334921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
    Talbot DC; Smith IE; Mansi JL; Judson I; Calvert AH; Ashley SE
    J Clin Oncol; 1991 Dec; 9(12):2141-7. PubMed ID: 1960556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
    Coleman RE; Maisey MN; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
    Huan SD; Natale RB; Stewart DJ; Sartiano GP; Stella PJ; Roberts JD; Symes AL; Finizio M
    Clin Cancer Res; 2000 Apr; 6(4):1333-6. PubMed ID: 10778959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.